medigraphic.com

2017, Number 3

<< Back Next >>

Cuba y Salud 2017; 12 (3)

Clinical-epidemiological-endoscopic-anatomopathological and microbiological characterization of patients with gastritis. Polyclinic April 19. 2012-2016

Duquesne AA, Rodríguez PY, Orellana MA

Language: Spanish
References: 37
Page: 39-45
PDF size: 241.93 Kb.


ABSTRACT

Objectives: To characterize patients diagnosed with gastritis from the clinical, epidemiological, endoscopic, pathological and microbiological point of view.
Materials and Methods: Cross-sectional descriptive study, in the 19 April Polyclinic from November 2012 to May 2016, to 230 patients with digestive symptoms with indication of endoscopy of the upper digestive tract. Two doses of gastric biopsy punches were taken for urease test and anatomopathological study, and an epidemiological survey was completed.
Results: From the sociodemographic point of view, the female sex predominated (62.6%), the white skin color (62.2%), the 40-49 age group (24.3%) and the average schooling (50.0%). Clinically, epigastric pain prevailed (64.8%) and post-pandrial fullness (56.1%). The consumption of coffee (65.7%) and that of soft drinks (63.5%) prevailed from the epidemiological point of view. Erythematous gastritis (84.8%) and chronic gastritis (80.4%) were of interest in endoscopy and biopsy, respectively. The majority of patients studied resulted in H. pylori negative (60.9%).
Conclusions: All the aspects taken into account in this research are of particular importance so that the attending physicians can impose an opportune pharmacological and hygienic treatment to these patients.


REFERENCES

  1. Yakirevich E, Resnick MB. Pathology of gastric cancer and its precursor lesions. Gastroenterol Clin North Am. 2013; 42(2):26.

  2. Gastritis and Gastropathies. In: Feldman M, et al. Sleisenger & Fordtran’s Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, and Management. 9th ed. Philadelphia, Pa: Saunders Elsevier; 2010 [citado Jun 9 2013]. . Disponible en: http://www.mdconsult.com/ books/about.do?eid=4-u1.0-B978-1-4160-6189.

  3. McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med. 2010; 362:1597–604.

  4. Moodley Y, Linz B, Bond RP, Nieuwoudt M, Soodyall H, Schlebusch CM, et al. Age of the association between Helicobacter pylori and man. PLoS Pathog. 2012; 8: 100-269.

  5. Roubaud Baudron C, Franceschi F, Salles N, Gasbarrini A. Extragastric diseases and Helicobacter pylori. Helicobacter. 2013; 18: 44-51.

  6. Mishra S. Is Helicobacter pylori good or bad? Eur J Clin Microbiol Infect Dis. 2013; 32: 301-304.

  7. Análisis de la Situación de Salud. Policlínico 19 de Abril. 2015.

  8. Gatta L, Ricci C, Tampieri A, Vaira D. Non-invasive techniques for the diagnosis of Helicobacter pylori infection. Clin Microbiol Infect. 2003; 9:489-96.

  9. Morales Espinosa MR, Castillo Rojas G, López Vidal Y, Cravioto A. Helicobacter pylori. 2006; 18: 48-60. Disponible en: http:// bibliomedweb.unam.mx/microbios/cap16.pdf. [Citado 23/12/2015].

  10. Cava F, Cobas G. Dos décadas de Helicobacter pylori. VacciMonitor. 2003; 12(1):1-10.

  11. Ministerio de Ciencia, Tecnología y Medio Ambiente. Resolución Nº 38. Lista Oficial de los Agentes Biológicos que afectan al hombre, los animales y las plantas. Gaceta Oficial República de Cuba. 2006; 56: 999-1001.

  12. Ministerio de Ciencia, Tecnología y Medio Ambiente. Resolución Nº 103. Reglamento para el establecimiento de los requisitos y procedimientos de seguridad biológica en las instalaciones en las que se hace uso de agentes biológicos y sus productos, organismos y fragmentos de estos con información genética. La Habana. CITMA.[en línea] 2002; 47: 78-89. Disponible en: http://www.medioambiente. cu/legislacione/resoluciones/R-103-02%20CITMA.htm. [Citado 16/06/2011].

  13. Lee YY, Mahendra Raj S, Graham DY: Helicobacter pylori infection - a boon or a bane: lessons from studies in a low-prevalence population. Helicobacter 2013, 18:338–346.

  14. Fabra Ricardo CE, Ulloa Arias B. Confirmación endoscópica de la gastritis por Helicobacter pylori en un centro médico venezolano de diagnóstico integral. MEDISAN. 2011; 15(10):1402.

  15. Galbán E, Arús E, Periles U. Hallazgos endoscópicos y factores de riesgo asociados en facilidades de Atención Primaria de Salud en La Habana, Cuba. MEDICC REVIEW. 2012; 14:23-27.

  16. Miftahussurur M, Tuda J, Suzuki R, Kido Y, Kawamoto F, Matsuda M, et al. Extremely low Helicobacter pylori prevalence in North Sulawesi, Indonesia and identification of a Maori-tribe type strain: a cross sectional study. Gut Pathogens. 2014 ; 6 : 42- 46. Disponible en: http://www.gutpathogens.com/content/6/1/42. [Citado 2/11/2016].

  17. Chen HL, Chen MJ, Shih SC, Wang HY, Lin IT, Bair MJ: Socioeconomic status, personal habits, and prevalence of Helicobacter pylori infection in the inhabitants of Lanyu. J Formos Med Assoc. 2014;113:278–283.

  18. Fernández Mendoza LE, Corrales Castañeda Y. Comportamiento de patologías diagnosticadas por endoscopia digestiva superior. Centro de Diagnóstico Integral de Yagua en el 2007. Rev Méd Electrón. 2009; 31(4): 15-19.

  19. Thrumurthy SG, Asif Chaudry M, Hochhauser D, Mughal M. Diagnóstico y manejo del cáncer gástrico. BMJ. 2013; 347: 6367. Disponible en: http://www.intramed.net/contenidover.asp?contenidoID=82274. [citado 12 Dic 2013]

  20. Monner Romero MR, Cruañes López L, Salazar Creagh A. Infección por Helicobacter Pylori en pacientes con síntomas digestivos. Revista Informacion Cientifica. 2012; 75(3): 87-91.

  21. Fernández Duharte J, Tacher Romano V, García Céspedes ME, Caro Fernández MT, Álvarez Guerra OM. Caracterización de los pacientes infectados por Helicobacter pylori durante un trienio. Hospital General Docente Dr. Juan Bruno Zayas Alfonso, Santiago de Cuba. MEDISAN. 2014; 18(7):951.

  22. Goh KL, Chan WK, Shiota S, Yamaoka Y. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter. 2011;16:1-9.

  23. Piñol Jiménez F, Paniagua Estévez M, Pérez Sánchez G, Gra Oramas B, Cendán Cordoví A, Borbolla Busquets E. Metaplasia intestinal en pacientes con reflujo duodenogástrico y ácidos biliares totales elevados. Revista Cubana de Medicina. 2010; 49(1): 17-32.

  24. Dehesa VM, Robles DG. Consenso Español sobre Helicobacter pylori. Rev Gastroenterol Esp. 2010; 62( 1 ): 41 – 5.

  25. Marrero Suárez Y, Martén Marén D, Bosch Castellanos JO, Ulloa Arias B, González de la Paz JE. Principales diagnósticos clinicoendscópicos e histológicos en ancianos con afecciones gastroduodenales. MEDISAN. 2014; 18(9): 1274.

  26. Rojas A, González I, Rodríguez B, Romero J, Figueroa H, Llanos J, et al. Evidence of involvement of the receptor for advanced glycation end-products (RAGE) in the adhesion of Helicobacter pylori to gastric epithelial cells. Microbes Infect. 2011; 13 (10): 818-23.

  27. Serrano M, Kikuste E, Dinis- Ribeiro M. Advanced endoscopic imaging for gastric cancer assessment: New insights with nwe optics? Best Practice & Research Clinical Gastroenterology. 2014; 28: 1079-1091.

  28. Zhang C, Yamada N, Wu YL, Wen M, Matsuhisa T, Matsukura N. Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer. World J Gastroenterol. 2005; 11(6): 791- 796.

  29. Ford AC, Forman D, Hunt RH, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and metha- analysis of randomised controlled trials. BMJ.2014; 348: 11.

  30. Fonseca Chong L, Torreblanca Xiques A . Aspectos clínicos y endoscópicos del adenocarcinoma gástrico en pacientes de Las Tunas, enero del 2013 a enero del 2014. Revista Electrónica Dr. Zoilo Marinello Vidaurreta. 2014; 39(5): 213-9.

  31. Loh JT, Shaffer CL, Piazuelo MB, Bravo LE, Correa P. Analysis of cagA in Helicobacter pylori strains from Colombia populations with contrasting gastric cancer risk reveals of biomarker of disease severity. Cancer Epidemiol Biomarjers Prev. 2011; 20: 2237-49.

  32. Yamashita K, Sakuramoto S, Nemoto M, Shibata T, Mieno H, Wataname M. Trends in gastric cancer: 35 years of surgical experience in Japan. World J Gastroenterol. 2011; 17(29): 3390-7.

  33. Uehara T, Ma D, Yao Y. H.pylori infection is associated with DNA damage of Lgr5-positive epithelial stem cells in the stomach of patients with gastric cancer. Dig Dis Sci. 2013; 58:140–9.

  34. Toljamo K, Niemelä SE, Karvonen AL, Karttunen R, Karttunen TJ. Histopathology of gastric erosions. Association with etiological factors and chronicity. Helicobacter.[en línea] 2011; [citado 16/06/2014]. 16(6): 444-51. Disponible en: http://onlinelibrary.wiley.com/ doi/10.1111/j.1523-5378.2011.00871.x/full.

  35. Matsushima K, Isomoto H, Inoue N, Nakayama T, Hayashi T, Nakayama M, et al. MicroRNA signatures in Helicobacter pylori-infected gastric mucosa. Int J Cancer.[en linea] 2011; 128(2): [citado 18 Jun 2014]. 361–70. Disponible: en: http://www.ncbi.nlm.nih.gov/pubm ed/?term=MicroRNA+signatures+in+Helicobacter+pylori-infected+gastric+mucosa.

  36. Morera Negre MM, Rodríguez López M. Dispepsia funcional: caracterización clínico epidemiológica y endoscópica. Rev. Ciencias Médicas. 2014; 18 (5): 733- 742.

  37. Alonso Soto J, Rodríguez González BL, Moreno Guerra A, Chao González L. Evaluación de la utilidad de diferentes métodos para el diagnóstico de Helicobacter pylori. Revista Cubana de Investigaciones Biomédicas. 2013; 32(1):102-110.




2020     |     www.medigraphic.com